Donated tumor tissue from a 5-year-old brain cancer patient uncovers the key and early role of a less-understood genetic mutation in the cancer’s fatal course.

Surgeon attitudes were the biggest driver of likelihood that patients receive contralateral prophylactic mastectomy, a new study finds.

Researchers have developed a fluidic device to track over time which cancer cells lead the disease’s invasive march.

Cancer progression can be spurred by TGF-beta pathway signaling, and Michigan Medicine researchers have found a way to stop the signal from turning green.

Worry about recurrence and radiation more often lead women to weigh double mastectomy.

See the research method and results of a study involving DNA and RNA sequencing of solid tumors and how these findings may inform precision cancer treatment.

A new study finds Fusobacterium nucleatum promotes resistance to chemotherapy in colon cancer patients. Read more about gut bacterium, f. nucleatum and colorectal cancer.

Read the results of a study investigating the role of family and friends in breast cancer treatment decisions and find out how physicians can use this information to guide conversations with patients.

See how a New York Law requiring physicians to communicate benefits of breast reconstruction to all mastectomy patients is reducing racial and ethnic disparities

Learn how the use of precision medicine and genetic sequencing are gaining traction within the research community and ongoing clinical trails.

After his own treatment for prostate cancer, one father and husband encourages all men to learn more about the disease.

A new study sheds light on the risk of blood clots at all stages of ovarian cancer and the potential need for preventive blood thinners during pre-surgery chemotherapy.

In the midst of glioblastoma treatment, radio interviews and editing strengthened a father-daughter bond — and helped their family cope.

A treatment usually used for adults has helped keep Nora stable since her diagnosis of stage 4 metastatic melanoma as a newborn.

How a new research initiative is empowering U-M physician-scientists to fight DIPG, one of the deadliest brain cancers, in innovative ways.